Published on
June 27, 2019
- 11:00 GMT
Valeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable Insulin ...
BRIDGEWATER, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, today announced it has filed a “Special 510(k): Device Modification” submission …
Distribution channels:
Banking, Finance & Investment Industry
...
